GlassScriptPhysician profile
Mitchell W Yadven
NPI 1679503353
$2,651.36
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $117 · 2021: $474 · 2022: $650 · 2023: $633 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $710.02 | 2019-2022 | |
| Axonics, INC. | $355.28 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $257.77 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $205.29 | 2023-2024 | Gemtesa, Orgovyx |
| Rochester Medical Corporation | $187.36 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $107.45 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $104.53 | 2019-2023 | Aveed, Edex, Xiaflex |
| Janssen Biotech, INC. | $81.61 | 2019-2023 | Erleada |
| Boston Scientific Corporation | $58.28 | 2019-2023 | Spaceoar Vue System - 10ml |
| Hollister Incorporated | $52.89 | 2023 | Vapro, Onli, Infyna Chic |
| Medtronic USA, INC. | $51.98 | 2019-2020 | |
| 180 Medical, INC. | $50.96 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.79 | 2023 | |
| Tolmar, INC. | $46.43 | 2023 | |
| Laborie Medical Technologies Corp. | $42.28 | 2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $40.68 | 2022 | |
| Abbvie INC. | $36.98 | 2022-2023 | Botox |
| Olympus America INC. | $35.15 | 2022-2023 | Itind System |
| Verity Pharmaceuticals INC. | $27.71 | 2022 | |
| Urovant Sciences INC | $20.71 | 2022 | |
| Blue Earth Diagnostics | $20.37 | 2019 | |
| Koelis INC. | $19.19 | 2023 | |
| Halozyme INC | $17.04 | 2023 | |
| Pfizer INC. | $16.86 | 2022 | |
| Antares Pharma, INC. | $16.68 | 2022 | |
| Medtronic, INC. | $14.72 | 2021 | |
| Angiodynamics, INC. | $13.26 | 2023 | Nanoknife |
| Tolmar Pharmaceuticals, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Yadven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.